The world's first low-cost in-ovo sexing solution to finally end chick culling

Omegga aims to eliminate chick culling by developing a low-cost, non-invasive spectral imaging solution for automated sex detection of chicken embryos in eggs.

Subsidie
€ 2.432.150
2024

Projectdetails

Introduction

Omegga - World’s first low-cost in-ovo sexing solution to finally end chick culling.

Background

In the egg-laying hen industry, over 7 billion day-old roosters are killed each year because male layer chickens neither lay eggs nor produce enough meat to be profitable.

Technology Overview

Omegga developed a cost-effective, non-invasive, spectral imaging solution for automating sex detection of chicken embryos in the eggs. This technology aims to avoid the unethical practice of chick culling by enabling hatcheries to:

  • Remove early male eggs from incubators
  • Only hatch female-layer chicks

The Omegga technology is based on absorption spectroscopy and tracks sex-specific biological indicators (proprietary method), enabling cost-effective, non-invasive, automated determination of an egg's sex.

Ethical and Regulatory Alignment

The solution aligns with ethical practices, supports sustainable farming, and meets emerging regulatory requirements against male chick culling.

Team and Development

Our team of 9 entrepreneurs, SW/HW/Bio engineers, data scientists, and veterinarians developed the technology and built & tested a first, small-scale industrial prototype.

Future Plans

Now we must create large-scale prototypes for full automation and optimize classification algorithms to minimize costs, for which we need EIC support.

Impact

Once implemented, it will boost resource efficiency and animal welfare in the poultry industry.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.432.150
Totale projectbegroting€ 3.474.500

Tijdlijn

Startdatum1-4-2024
Einddatum31-3-2026
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • OMEGGA GMBHpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

A new cardioprotective drug for acute treatment of myocardial infarction

ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.

€ 2.499.999
EIC Accelerator

"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""

NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.

€ 2.306.500
EIC Accelerator

Autonomous robotics and digital TWIN to improve water network performances

The project develops a robotic inspection system for water utilities, enabling autonomous pipeline assessments to enhance water quality and sustainability through a subscription-based RaaS model.

€ 2.478.210
EIC Accelerator

Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system

Toopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability.

€ 2.396.457

Vergelijkbare projecten uit andere regelingen

MIT Haalbaarheid

Een monitoringssysteem voor voorspelling en verbetering van het broedproces t.b.v. duurzame en diervriendelijke pluimveehouderij

In Ovo ontwikkelt een analysetool voor hun sensorensysteem Eve om het broedproces van kippen te optimaliseren en de kosten te verlagen, terwijl de haalbaarheid wordt onderzocht.

€ 20.000
MIT Haalbaarheid

High-throughput geslachtsbepaling van kippeneieren

In Ovo onderzoekt een innovatie voor snellere geslachtsbepaling van kippeneierembryo's om de efficiëntie en dierenwelzijn in de pluimveehouderij te verbeteren.

€ 20.000
MIT Haalbaarheid

EggSPECT

Het EggSPECT-project onderzoekt de haalbaarheid van geslachtsbepaling van bevruchte kippeneieren met een nieuwe sensor, zonder het ei te beschadigen.

€ 20.000
MIT Haalbaarheid

Scanner voor vroege, niet invasieve in-ovo ei classificering

Meluna Research B.V. onderzoekt de haalbaarheid van een geautomatiseerde scanner met meervoudige sensortechnologie voor vroege in-ovo ei classificering binnen 5 dagen na het leggen.

€ 20.000